Maryland stands as a shining example of a medical cannabis state transitioning smoothly into the recreational market. According to a financial report by Zuanic & Associates, (Z&A), this transition has been particularly beneficial for incumbent medical cannabis players, who have witnessed a remarkable doubling of their sales and a resurgence in prices.

Key Highlights: Sales Surge And Market Share

Pablo Zuanic, chief analyst at Z&A, will be featured as a keynote speaker at the upcoming Benzinga Cannabis Capital Conference, in Chicago this September 27-28. Get your tickets today before prices increase and secure a spot at the epicenter of cannabis investment and branding.

Full story available on Benzinga.com

A note to our visitors

This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.